For example, branaplam, originally developed as spinal muscular atrophy therapy, was recently discovered to induce the splice-in of a pseudoexon in Htt mRNA, destabilizing the transcript, inducing its degradation, and improving the motor performance in Htt mouse models [17]. Here, HTT is linked to spinal muscular atrophy.